Meta-analysis of probiotics for the treatment of irritable bowel syndrome
Open Access
- 1 January 2008
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (17), 2650-2661
- https://doi.org/10.3748/wjg.14.2650
Abstract
Irritable bowel syndrome (IBS) is a chronic condition affecting 3%-25% of the general population. As no curative treatment is available, therapy is aimed at reducing symptoms, often with little success. Because alteration of the normal intestinal microflora has been observed in IBS, probiotics (beneficial microbes taken to improve health) may be useful in reducing symptoms. This paper systematically reviews randomized, controlled, blinded trials of probiotics for the treatment of IBS and synthesizes data on efficacy across trials of adequate quality. PubMed, Medline, Google Scholar, NIH registry of clinical trials, metaRegister, and the Cochrane Central Register of Controlled Trials were searched from 1982-2007. We also conducted secondary searches of reference lists, reviews, commentaries, relevant articles on associated diseases, books and meeting abstracts. Twenty trials with 23 probiotic treatment arms and a total of 1404 subjects met inclusion criteria. Probiotic use was associated with improvement in global IBS symptoms compared to placebo [pooled relative risk (RRpooled) 0.77, 95% confidence interval (95% CI) 0.62-0.94]. Probiotics were also associated with less abdominal pain compared to placebo [RRpooled = 0.78 (0.69-0.88)]. Too few studies reported data on other IBS symptoms or on specific probiotic strains to allow estimation of a pooled RR. While our analyses suggest that probiotic use may be associated with improvement in IBS symptoms compared to placebo, these results should be interpreted with caution, given the methodological limitations of contributing studies. Probiotics warrant further study as a potential therapy for IBS.Keywords
This publication has 67 references indexed in Scilit:
- Guidelines on the irritable bowel syndrome: mechanisms and practical managementGut, 2007
- Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up studyGut, 2007
- Role of infection in irritable bowel syndromeThe Esophagus, 2007
- Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to dateNeurogastroenterology & Motility, 2006
- A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trialJournal of Zhejiang University-SCIENCE B, 2006
- Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trialsThe Journal of Pediatrics, 2006
- The Use of Lactobacillus GG in Irritable Bowel Syndrome in Children: A Double-blind Randomized Control TrialThe Journal of Pediatrics, 2005
- Irritable Bowel Syndrome: Epidemiology, Natural History, Health Care Seeking and Emerging Risk FactorsGastroenterology Clinics of North America, 2005
- Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statementBritish Journal of Surgery, 2000
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986